These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22493277)

  • 21. Distribution, virulence attributes and antifungal susceptibility patterns of Candida parapsilosis complex strains isolated from clinical samples.
    Tosun I; Akyuz Z; Guler NC; Gulmez D; Bayramoglu G; Kaklikkaya N; Arikan-Akdagli S; Aydin F
    Med Mycol; 2013 Jul; 51(5):483-92. PubMed ID: 23216051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular differentiation and antifungal susceptibilities of Candida parapsilosis isolated from patients with bloodstream infections.
    Tay ST; Na SL; Chong J
    J Med Microbiol; 2009 Feb; 58(Pt 2):185-191. PubMed ID: 19141735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Candida parapsilosis sensu stricto and the closely related species Candida orthopsilosis and Candida metapsilosis in vulvovaginal candidiasis.
    Zhu Y; Shan Y; Fan S; Li J; Liu X
    Mycopathologia; 2015 Feb; 179(1-2):111-8. PubMed ID: 25322705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular identification and in vitro antifungal susceptibility of blood isolates of the Candida parapsilosis species complex in Venezuela].
    Moreno X; Reviakina V; Panizo MM; Ferrara G; García N; Alarcón V; Garcés MF; Dolande M
    Rev Iberoam Micol; 2017; 34(3):165-170. PubMed ID: 28457646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Species distribution and antifungal susceptibility among clinical isolates of Candida parapsilosis complex from India.
    Maria S; Barnwal G; Kumar A; Mohan K; Vinod V; Varghese A; Biswas R
    Rev Iberoam Micol; 2018; 35(3):147-150. PubMed ID: 29997030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of commercial methods and the CLSI broth microdilution to determine the antifungal susceptibility of Candida parapsilosis complex bloodstream isolates from three health institutions in Rio de Janeiro, Brazil.
    Figueiredo-Carvalho MH; Barbedo LS; Oliveira MM; Brito-Santos F; Almeida-Paes R; Zancopé-Oliveira RM
    Mycopathologia; 2014 Aug; 178(1-2):27-35. PubMed ID: 24952718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Identification, Genotypic Diversity, Antifungal Susceptibility, and Clinical Outcomes of Infections Caused by Clinically Underrated Yeasts,
    Arastehfar A; Khodavaisy S; Daneshnia F; Najafzadeh MJ; Mahmoudi S; Charsizadeh A; Salehi MR; Zarrinfar H; Raeisabadi A; Dolatabadi S; Zare Shahrabadi Z; Zomorodian K; Pan W; Hagen F; Boekhout T
    Front Cell Infect Microbiol; 2019; 9():264. PubMed ID: 31417877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil.
    Gonçalves SS; Amorim CS; Nucci M; Padovan AC; Briones MR; Melo AS; Colombo AL
    Clin Microbiol Infect; 2010 Jul; 16(7):885-7. PubMed ID: 19686280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro efficacy of 5 antifungal agents against Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis as determined by time-kill methodology.
    Szabó Z; Szilágyi J; Tavanti A; Kardos G; Rozgonyi F; Bayegan S; Majoros L
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):283-8. PubMed ID: 19394787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virulence factors, antifungal susceptibility and molecular mechanisms of azole resistance among Candida parapsilosis complex isolates recovered from clinical specimens.
    Neji S; Hadrich I; Trabelsi H; Abbes S; Cheikhrouhou F; Sellami H; Makni F; Ayadi A
    J Biomed Sci; 2017 Sep; 24(1):67. PubMed ID: 28870262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid molecular differentiation and genotypic heterogeneity among Candida parapsilosis and Candida orthopsilosis strains isolated from clinical specimens in Kuwait.
    Asadzadeh M; Ahmad S; Al-Sweih N; Khan ZU
    J Med Microbiol; 2009 Jun; 58(Pt 6):745-752. PubMed ID: 19429750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis.
    Miranda-Cadena K; Marcos-Arias C; Mateo E; Aguirre JM; Quindós G; Eraso E
    Arch Oral Biol; 2018 Nov; 95():100-107. PubMed ID: 30096698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis.
    Lockhart SR; Messer SA; Pfaller MA; Diekema DJ
    J Clin Microbiol; 2008 Aug; 46(8):2659-64. PubMed ID: 18562582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspartyl proteinase, phospholipase, esterase and hemolysin activities of clinical isolates of the Candida parapsilosis species complex.
    Treviño-Rangel Rde J; González JG; González GM
    Med Mycol; 2013 Apr; 51(3):331-5. PubMed ID: 22928925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Candidaemia due to Candida parapsilosis species complex at a hospital in Brazil: Clinical characteristics and antifungal susceptibility profile.
    Alencar DSO; Tsujisaki RAS; Spositto FLE; Nunes MO; Almeida AA; Martins MDA; Melhem MSC; Chang MR
    Rev Iberoam Micol; 2017; 34(2):106-108. PubMed ID: 28214273
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Zhang W; Zhan M; Wang N; Fan J; Han X; Li C; Liu J; Li J; Hou Y; Wang X; Zhang Z
    J Med Microbiol; 2023 Mar; 72(3):. PubMed ID: 36920840
    [No Abstract]   [Full Text] [Related]  

  • 38. Species distribution, virulence factors, and antifungal susceptibility among Candida parapsilosis complex isolates from clinical specimens at Siriraj Hospital, Thailand, from 2011 to 2015.
    Pharkjaksu S; Chongtrakool P; Suwannakarn K; Ngamskulrungroj P
    Med Mycol; 2018 Jun; 56(4):426-433. PubMed ID: 28992058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and echinocandin susceptibility of Candida parapsilosis sensu lato species isolated from bloodstream infections at a Spanish university hospital.
    Garcia-Effron G; Canton E; Pemán J; Dilger A; Romá E; Perlin DS
    J Antimicrob Chemother; 2012 Nov; 67(11):2739-48. PubMed ID: 22868644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization and antifungal susceptibility of the Candida parapsilosis species complex of clinical isolates from Monterrey, Mexico.
    Treviño-Rangel Rde J; Garza-González E; González JG; Bocanegra-García V; Llaca JM; González GM
    Med Mycol; 2012 Oct; 50(7):781-4. PubMed ID: 22493945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.